Ask anyone in the US about COVID-19 vaccines, and they usually will think of either “Moderna” or “Pfizer,” which are popular shorthand for Moderna, Inc.’s Spikevax and Pfizer Inc./BioNTech SE’s Comirnaty. What they often don’t know is the enormous amount of effort and coordination across government, drug makers, academia and communities that went into making those vaccines possible.
A report published 23 January in JAMA details the creation of the COVID-19 Prevention Network (CoVPN), part of Operation Warp...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?